000 01459 a2200421 4500
005 20250513191013.0
264 0 _c19991028
008 199910s 0 0 eng d
022 _a1043-0342
024 7 _a10.1089/10430349950017491
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYao, F
245 0 0 _aA novel anti-herpes simplex virus type 1-specific herpes simplex virus type 1 recombinant.
_h[electronic resource]
260 _bHuman gene therapy
_cJul 1999
300 _a1811-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntiviral Agents
650 0 4 _aBlotting, Southern
650 0 4 _aBlotting, Western
650 0 4 _aChlorocebus aethiops
650 0 4 _aDNA-Binding Proteins
_xgenetics
650 0 4 _aElectrophoresis, Polyacrylamide Gel
650 0 4 _aGene Expression Regulation, Viral
650 0 4 _aGenetic Therapy
650 0 4 _aGenetic Vectors
650 0 4 _aHerpesvirus 1, Human
_xgenetics
650 0 4 _aRecombination, Genetic
650 0 4 _aReplication Origin
650 0 4 _aRepressor Proteins
_xgenetics
650 0 4 _aTumor Cells, Cultured
650 0 4 _aVero Cells
650 0 4 _aViral Proteins
_xgenetics
650 0 4 _aVirus Replication
700 1 _aEriksson, E
773 0 _tHuman gene therapy
_gvol. 10
_gno. 11
_gp. 1811-8
856 4 0 _uhttps://doi.org/10.1089/10430349950017491
_zAvailable from publisher's website
999 _c10404643
_d10404643